Latest Financial News
MeiraGTx soars on FDA breakthrough therapy, revenue surge
Gene therapy developer reports $81.4M revenue from strategic Lilly and Hologen partnerships, extends cash runway to 2027
CMC dividend rises 11% as core EBITDA surges 114%
Adjusted EPS missed estimates on acquisition charges, but underlying operations show strong margin expansion and earnings growth
Qualcomm sinks as Bernstein slashes price target on smartphone decline
Analyst Stacy Rasgon cuts rating to Market Perform, citing memory headwinds and Apple transition risks
Micron falls 3.4% as Google's TurboQuant reduces AI memory needs
Algorithm slashes memory requirements by 6x, raising questions about future chip demand despite sold-out HBM supply
WBD shares trade at 12% discount ahead of April 23 Paramount merger vote
Shareholders set to vote on $31 per cash share acquisition as regulatory scrutiny and debt concerns weigh on deal prospects
Upstream Bio surges 12% on Phase 3 asthma strategy
Strong cash position of $341.5M supports development through 2027 as company targets $40B asthma market with TSLP inhibitor
Acumen posts $121.3M loss, cash burn accelerates before key Alzheimer's trial
Clinical-stage biotech reports $115.5M operating cash burn as it awaits late 2026 ALTITUDE-AD Phase 2 data
EU Parliament advances US trade deal with safeguards; vote 417-154
Tariff elimination on US industrial goods set to boost exporters, deal faces final approval in April-May